Related Experiment Video
Updated: Mar 24, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
13.3K
Pharmacogenomics for personalized pain medicine
Tai-Ming Ko1, Chih-Shung Wong2, Jer-Yuarn Wu3
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
Summary
Pharmacogenomics uses genetic variation to personalize pain medication, improving drug efficacy and preventing adverse drug reactions (ADRs). This approach optimizes pain management by tailoring treatments to individual genetic profiles.
Area of Science:
- Pharmacogenomics
- Genetics
- Pain Management
Background:
- Pain management is challenging due to variable drug efficacy and adverse drug reactions (ADRs).
- Individual genetic variations significantly influence responses to pain medications.
- Pharmacogenomics offers a pathway to optimize pain treatment strategies.
Purpose of the Study:
- To review recent pharmacogenomic studies on adverse drug reactions (ADRs) and drug efficacy in pain management.
- To highlight the role of genetic variation in individual responses to pain medications.
- To discuss the application of pharmacogenomics for personalized pain therapy.
Main Methods:
- Literature review of pharmacogenomic studies.
- Analysis of genetic association studies (GWAS) and candidate gene findings.
- Synthesis of current research on drug efficacy and ADRs in pain management.
Main Results:
- Genetic variations impact both the effectiveness and toxicity of pain drugs.
- Pharmacogenomic approaches can guide the selection of optimal drugs and dosages.
- Personalized medicine strategies show promise in reducing ADRs and improving pain relief.
Conclusions:
- Pharmacogenomics is crucial for understanding and mitigating variability in pain medication outcomes.
- Genetic insights enable tailored pain management, enhancing patient safety and treatment success.
- Future research should focus on integrating pharmacogenomics into routine clinical pain management.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
01:29Pharmacogenetics and Pharmacogenomics: Overview
137
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
137
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
108
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
01:27Pharmacogenetics of Drug Metabolism: Overview
106
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
106
01:27Principles of Pharmacogenetics: Types of Genetic Variants
87
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
87
01:25Analgesia and Pain Management
2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K